Kewaunee Scientific Stock Intrinsic Value – Kewaunee Scientific Reports $0.93 GAAP EPS and $50.44M Revenue
December 7, 2023
🌥️Trending News
The company reported a revenue of $50.44M and a GAAP Earnings Per Share (EPS) of $0.93. Kewaunee Scientific ($NASDAQ:KEQU) is a leading manufacturer of laboratory, healthcare, and technical furniture and fume hoods in the United States. The company’s earnings report is expected to help the company continue to grow in the coming years. This strong financial position will help the company fund future growth plans and maximize shareholder value.
Overall, Kewaunee Scientific is in a strong position to take advantage of opportunities in the laboratory furniture and fume hoods market. With their quarterly earnings report, they have set the stage for continued success in the coming years.
Earnings
KEWAUNEE SCIENTIFIC recently released its earning report of FY2024 Q1 ending July 31 2021, in which the company reported 39.49M USD in total revenue and 1.34M USD in net income. Comparatively, this was a 21.2% decrease in total revenue from the previous year. However, KEWAUNEE SCIENTIFIC’s total revenue has seen a steady increase over the last three years, reaching 49.84M USD. The company reported $0.93 GAAP EPS and $50.44M Revenue for FY2024 Q1.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Kewaunee Scientific. More…
| Total Revenues | Net Income | Net Margin |
| 219.21 | 3.96 | 1.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Kewaunee Scientific. More…
| Operations | Investing | Financing |
| 0.7 | -5.41 | 4.57 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Kewaunee Scientific. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 124.82 | 84.28 | 13.69 |
Key Ratios Snapshot
Some of the financial key ratios for Kewaunee Scientific are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 14.9% | -28.2% | 4.6% |
| FCF Margin | ROE | ROA |
| -2.2% | 16.3% | 5.0% |
Price History
This was a better-than-expected performance for the company, which resulted in the stock price seeing an increase of 3.0% from prior closing price of 17.1 to open at $17.8 and close at $17.6. This positive performance of the stock not only indicates a strong financial condition of the company but also provides investors with a confidence that their investment in KEWAUNEE SCIENTIFIC is safe. Live Quote…
Analysis – Kewaunee Scientific Stock Intrinsic Value
At GoodWhale, we conducted an analysis of KEWAUNEE SCIENTIFIC‘s wellbeing and used our proprietary Valuation Line to determine the fair value of KEWAUNEE SCIENTIFIC’s share to be around $17.4. Currently, KEWAUNEE SCIENTIFIC stock is traded at $17.6, which is a fair price in our opinion. We believe that KEWAUNEE SCIENTIFIC is in a good position and investors should consider investing in it. More…
Peers
Kewaunee Scientific Corp, Siam Steel International PCL, Varangis Avepe SA, and PT Gema Graha Sarana Tbk are leading international corporations in the laboratory furniture and equipment industry. They are highly competitive in this sector, providing top-notch products and services that cater to the needs of their customers. Each company has its own unique strengths and rigorous processes that make them stand out from the rest.
– Siam Steel International PCL ($SET:SIAM-R)
Siam Steel International PCL is a leading steel manufacturer in Thailand. It produces a wide range of steel products, including automotive parts, construction materials, and agricultural machinery. As of 2023, the company has a market capitalization of 830.38M, indicating investor confidence in the company’s long-term prospects. The company has a negative Return on Equity (ROE) of -0.78%, which is an indicator that it is not generating enough returns from its investments. Despite this, Siam Steel International PCL has continued to be successful in providing quality steel products to its customers.
– Varangis Avepe SA ($LTS:0QC6)
Gema Graha Sarana Tbk is a publicly traded Indonesian company that specializes in investment holding and property management. The company’s market cap of 406.4B as of 2023 is a reflection of its robust financial position and profitability. Furthermore, the company’s Return on Equity (ROE) stands at 13.37%, highlighting its strong ability to generate profits from its shareholders’ investment. All of these factors illustrate the strength of Gema Graha Sarana Tbk as one of the largest and most successful companies in Indonesia.
Summary
Kewaunee Scientific is a stock worth considering for investors. The company reported a GAAP EPS of $0.93 and revenue of $50.44M, which was higher than expected. This news caused the stock price to move up on the same day, suggesting that investors believe in the company’s prospects for future growth. Analyzing the financials of Kewaunee Scientific can help investors make informed decisions when considering investing in this stock. With its strong EPS and revenue, it could be a good option for those looking for stable returns in the long-term.
Additionally, it’s important to consider the company’s past performance and future outlook when considering investing in Kewaunee Scientific.
